EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Discovery to Cure—Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999–2023)

Ashraf Ullah, Hina Wazir, Abdullah Sultany iD, Khalil Ur Rehman, Mohammad Ibrahim Sultani, Naeem Ahmed Khan iD, Saeed A Khan, Mati Ullah Dad Ullah, Amlish Gondal

Viruses · 20.05.2026 · 18 (5) · 576

DOI: 10.3390/v18050576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 20.05.2026. Verfasst von Ashraf Ullah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA 18840, USA. Hauptthemen laut MEDLINE: Hepatitis C, Chronic. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C virus (HCV) remains a major cause of preventable liver-related mortality in the United States despite highly effective direct-acting antivirals (DAAs). Contemporary assessment of mortality trends and disparities is essential for elimination efforts.

Methods

Using CDC WONDER multiple cause-of-death data (1999–2023), we identified HCV-related deaths using ICD-10 codes for acute and chronic HCV (B17.1, B18.2) and calculated age-adjusted mortality rates (AAMRs) per 100,000 (2000 US standard). Rates were stratified by sex, race/ethnicity, census region, and 2013 NCHS urban–rural classification. Joinpoint regression quantified temporal inflection points and annual percent changes (APCs).

Results

Overall HCV-related AAMR increased from 1.8 (1999) to a peak of 5.0 (2014), then declined to 2.3 (2023), with a marked post-2014 decrease (APC −8.2%). Mortality was consistently higher in males than females (2023 rate ratio 2.57). In 2023, American Indian/Alaska Native individuals had the highest mortality (AAMR 8.7; rate ratio 3.48 vs. non-Hispanic White), followed by non-Hispanic Black individuals (AAMR 6.2; rate ratio 2.48). Mortality remained highest in the West and was higher in non-metropolitan than metropolitan counties (AAMR 2.8 vs. 2.3; rate ratio 1.22), with a slower post-2014 decline in non-metropolitan areas.

Conclusions

Our findings indicate that while the DAA era has been associated with a substantial reduction in HCV-related mortality at the national level, this progress has not been uniform across all populations. Persistent excess mortality among Native American and non-Hispanic Black individuals may reflect inequities in the HCV care cascade, including screening, confirmatory testing, linkage to specialty care, insurance-related restrictions, and the high cost of antiviral therapy. These results highlight the need for policies and public health strategies that improve equitable and affordable access to curative HCV treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicHumansUnited StatesFemaleMaleAntiviral AgentsCenters for Disease Control and Prevention, U.S.Databases, FactualHepacivirusAged

Stichwörter der Autor:innen

CDC WONDERdirect-acting antiviralshealth disparitieshepatitis Cmortality

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA 18840, USA.
  • Jamaica Hospital Medical Center, Richmond Hill, New York City, NY 11418, USA.
  • Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL 61801, USA.
  • Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Türkiye.
  • Department of Internal Medicine, NYC Health + Hospitals/Woodhull, Brooklyn, NY 11206, USA.
  • Ghurki Trust Teaching Hospital, Lahore 54000, Pakistan.

ORCID-Profile: Abdullah Sultany, Naeem Ahmed Khan

Zitieren

APA

Ullah, A., Wazir, H., Sultany, A., Rehman, K. U., Sultani, M. I., Khan, N. A., Khan, S. A., Ullah, M. U. D., & Gondal, A. (2026). From Discovery to Cure—Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999–2023). Viruses, 18(5), 576. https://doi.org/10.3390/v18050576

Vancouver

Ullah A, Wazir H, Sultany A, Rehman KU, Sultani MI, Khan NA, et al. From Discovery to Cure—Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999–2023). Viruses. 2026;18(5):576. doi:10.3390/v18050576

BibTeX
@article{Ullah2026,
  author = {Ullah, Ashraf and Wazir, Hina and Sultany, Abdullah and Rehman, Khalil Ur and Sultani, Mohammad Ibrahim and Khan, Naeem Ahmed and Khan, Saeed A and Ullah, Mati Ullah Dad and Gondal, Amlish},
  title = {From Discovery to Cure—Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999–2023)},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {576},
  doi = {10.3390/v18050576}
}
Kostenlos starten →